This protocol is judged by an institutional evaluate board, an unbiased team that assessments any scientific trials involving human beings. If a study requires a Timetable I drug, as soon as the board approves the protocol as moral, the researchers have to submit an application for an investigational new drug (IND) selection from the FDA.Though the